Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,536.65
(
0.85%
)
US TECH 100
29,214.44
(
1.79%
)
Dow Jones
50,593.52
(
0.03%
)
Brent Oil
97.42
(
-3.71%
)
Bitcoin
76,800.68
(
-0.59%
)
News Focus
News Focus
Post# of 2382038
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TheTradeTrain

Send PM Follow Ignore
Followers 7
Posts 446
Boards Moderated 0
Alias Born 11/14/2018

TheTradeTrain

Re: None

Thursday, 01/17/2019 6:08:30 AM

Thursday, January 17, 2019 6:08:30 AM

Post# of 2382038
Q BioMed Inc (OTCMKTS:QBIO) shares continue to act well amid a flurry of important catalysts. We covered the stock in a recent profile [HERE].

Among these catalysts now in play for the stock, we saw analysts at Brookline Capital Markets initiate coverage of the biotech accelerator firm with a ‘buy’ recommendation and a $16/share price target, which represents nearly a 10x upside from present levels.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today